DFDA

Supportive Care

Treatment for Acute Hepatitis E

Typical Dosage: Not applicable

Effectiveness
80%
Safety Score
95%
Clinical Trials
5,000
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Not applicable
Time to Effect
2-4 weeks
Treatment Duration
Weeks to months (until recovery)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$450
Side Effect Mgmt:$100
Total Annual:$550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0
Outcome-Based Costs
Cost per Responder
$561.22
Cost per Remission
$561.22
Supportive Care Outcomes

for Acute Hepatitis E

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+98%
Remission Rate
+98%

Sources:

nih.gov
bmj.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov